12 AI Stocks Making Headlines: Latest News and Ratings

Page 2 of 11

10. IGC Pharma, Inc. (NYSE:IGC)

Number of Hedge Fund Holders: 3

IGC Pharma, Inc. (NYSE:IGC) is a pharmaceutical company engaged in developing treatments for Alzheimer’s disease. The company integrates cutting-edge AI technologies into its drug discovery processes. On March 4, IGC Pharma announced that it has advanced its Artificial Intelligence platform with the development of a new AI-driven model. The model aims to improve the diagnosis of Alzheimer’s disease (AD) and other causes of dementia.  Trained on multi-modal clinical data from leading public research databases, it analyzes neuroimaging biomarkers, cognitive assessments, genetic risk factors, medical history, neurological exams, and demographic information to enable precision in its diagnostic framework. As a result, reliable, personalized insights can be generated across different patient populations.

“The AI model is a potential game changer for our growth strategy. Our AI platform is a key driver of IGC Pharma’s long-term growth strategy, reinforcing our commitment to precision medicine and targeted treatments for neurodegenerative diseases. Misdiagnosis remains a significant challenge, often delaying treatment for patients who need it most. Our AI-driven model aims to close this gap, ultimately improving patient outcomes.”

-Ram Mukunda, CEO of IGC Pharma.

Page 2 of 11